Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Spinal Muscular Atrophies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00485511
What this trial is testing

A Trial of Hydroxyurea in Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular Atrophy
Kaohsiung Medical University Chung-Ho Memorial Hospital
Testing effectiveness (Phase 2)Study completedNCT00568698
What this trial is testing

A Pilot Therapeutic Trial Using Hydroxyurea in Type I Spinal Muscular Atrophy Patients

Who this might be right for
Muscular Atrophy, Spinal
Stanford University 29
Not applicableNot Yet RecruitingNCT07325149
What this trial is testing

The Effect of Exoskeletal-assisted Walking Combined With Transcutaneous Spinal Cord Stimulation on Bone Strength.

Who this might be right for
Secondary OsteoporosisSarcopenia
Bronx VA Medical Center 24
Early research (Phase 1)Ended earlyNCT03478904
What this trial is testing

Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Study completedNCT01302600
What this trial is testing

Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients.

Who this might be right for
Spinal Muscular Atrophy Type IISpinal Muscular Atrophy Type III Non Ambulant
Hoffmann-La Roche 165
Not applicableLooking for participantsNCT07136844
What this trial is testing

Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology

Who this might be right for
Neuromuscular DiseasesObesity (Disorder)Myotonic Dystrophy 1+9 more
Centre Hospitalier Universitaire de Liege 300
Not applicableUnknownNCT05107349
What this trial is testing

Cell Signaling, Reinnervation and Metabolism in Kennedy Disease and Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisKennedy Disease
Assistance Publique - Hôpitaux de Paris 40
Not applicableStudy completedNCT03689660
What this trial is testing

Feasibility of Virtual Reality in Children With Neuromuscular Disease, Effectiveness of Virtual Reality and Biofeedback

Who this might be right for
Neuromuscular DiseaseDuchenne Muscular DystrophySpinal Muscular Atrophy+2 more
Merve Kurt 24
Not applicableUnknownNCT03561623
What this trial is testing

Spinal Cord Gray Matter Imaging in Post Polio Syndrome

Who this might be right for
Post-polio Syndrome
University Hospital, Basel, Switzerland 40
Post-approval studies (Phase 4)Looking for participantsNCT07448610
What this trial is testing

ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)

Who this might be right for
Spinal Muscular Atrophy
Novartis Pharmaceuticals 36
Not applicableStudy completedNCT04228718
What this trial is testing

The Burden of Primary Caregivers of Spinal Muscular Atrophy Patients and Their Needs

Who this might be right for
Spinal Muscular AtrophyCaregiver Burden
Marmara University 34
Not applicableActive Not RecruitingNCT05618379
What this trial is testing

Adult Spinal Muscular Atrophy (SMA) China Registry

Who this might be right for
Muscular Atrophy, Spinal
Biogen 200
Testing effectiveness (Phase 2)Study completedNCT02913482
What this trial is testing

Investigate Safety, Tolerability, PK, PD and Efficacy of Risdiplam (RO7034067) in Infants With Type1 Spinal Muscular Atrophy

Who this might be right for
Muscular Atrophy, Spinal
Hoffmann-La Roche 62
Testing effectiveness (Phase 2)Study completedNCT01703988
What this trial is testing

An Open-label Safety, Tolerability and Dose-Range Finding Study of Multiple Doses of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular Atrophy
Biogen 34
Large-scale testing (Phase 3)Active Not RecruitingNCT05337553
What this trial is testing

Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular AtrophyNeuromuscular DiseasesSMA
Biohaven Pharmaceuticals, Inc. 269
Testing effectiveness (Phase 2)Study completedNCT02268552
What this trial is testing

An Open Label Study of LMI070 (Branaplam) in Type 1 Spinal Muscular Atrophy (SMA)

Who this might be right for
Spinal Muscular Atrophy
Novartis Pharmaceuticals 40
Not applicableUnknownNCT04825119
What this trial is testing

Hyperkinetic Movements in Patients With Disease of Motor Neurons and Their Response to Treatment With Nusinersen

Who this might be right for
TremorInvoluntary MovementsSMA+1 more
University Medical Centre Ljubljana 110
Early research (Phase 1)Study completedNCT03920865
What this trial is testing

Investigate the Effect of Hepatic Impairment on the Pharmacokinetics and Safety and Tolerability of a Single Oral Dose of Risdiplam Compared to Matched Healthy Participants With Normal Hepatic Function

Who this might be right for
Muscular Atrophy, Spinal
Hoffmann-La Roche 26
Testing effectiveness (Phase 2)Looking for participantsNCT05747261
What this trial is testing

Study of the Safety and Efficacy of an Adeno-Associated Viral Vector Carrying the SMN Gene After a Single Intravenous Administration of Escalating Doses in Children With Spinal Muscular Atrophy (BLUEBELL)

Who this might be right for
Spinal Muscular Atrophy (SMA)
Biocad 40
Early research (Phase 1)Study completedNCT01052870
What this trial is testing

Association of Polymorphisms in the Androgen Receptor Gene and Finasteride Response in Women With Androgenetic Alopecia

Who this might be right for
Androgenetic Alopecia
HairDx, LLC 12
Next Page